These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34001777)

  • 1. The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia.
    Singh D; Narayanan S; Vicknasingam B; Prozialeck WC; Smith KE; Corazza O; Henningfield JE; Grundmann O
    J Addict Med; 2022 Mar-Apr 01; 16(2):223-228. PubMed ID: 34001777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Benzodiazepines among Kratom (
    Singh D; Narayanan S; Grundmann O; Boyer EW; Vicknasingam B
    J Psychoactive Drugs; 2020; 52(1):86-92. PubMed ID: 31218929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (
    Saref A; Suraya S; Singh D; Grundmann O; Narayanan S; Swogger MT; Prozialeck WC; Boyer E; Balasingam V
    J Psychoactive Drugs; 2020; 52(2):138-144. PubMed ID: 31682782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported prevalence and severity of opioid and kratom (Mitragyna speciosa korth.) side effects.
    Saref A; Suraya S; Singh D; Grundmann O; Narayanan S; Swogger MT; Prozialeck WC; Boyer E; Chear NJY; Balasingam V
    J Ethnopharmacol; 2019 Jun; 238():111876. PubMed ID: 31014959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Kratom (
    Singh D; Narayanan S; Grundmann O; Dzulkapli EB; Vicknasingam B
    Subst Use Misuse; 2019; 54(14):2284-2289. PubMed ID: 31347441
    [No Abstract]   [Full Text] [Related]  

  • 6. Public Perceptions toward Kratom (
    Singh D; Narayanan S; Suraya S; Saref A; Grundmann O; Prozialeck WC; Corazza O; Swogger MT; Griffin O; Balasingam V
    J Psychoactive Drugs; 2020; 52(3):282-288. PubMed ID: 32153252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.
    Singh D; Müller CP; Murugaiyah V; Hamid SBS; Vicknasingam BK; Avery B; Chear NJY; Mansor SM
    J Ethnopharmacol; 2018 Mar; 214():197-206. PubMed ID: 29248450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of gonadotropins and testosterone hormone levels in regular Mitragyna speciosa (Korth.) users.
    Singh D; Murugaiyah V; Hamid SBS; Kasinather V; Chan MSA; Ho ETW; Grundmann O; Chear NJY; Mansor SM
    J Ethnopharmacol; 2018 Jul; 221():30-36. PubMed ID: 29626673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of Kratom (Mitragyna speciosa Korth.) Psychological Withdrawal Symptoms.
    Singh D; Narayanan S; Müller CP; Swogger MT; Rahim AA; Leong Bin Abdullah MFI; Vicknasingam BK
    J Psychoactive Drugs; 2018; 50(5):445-450. PubMed ID: 30152738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of Pain and Sleep Problems during Kratom (Mitragyna speciosa Korth.) Cessation among Regular Kratom Users.
    Singh D; Narayanan S; Vicknasingam BK; Prozialeck WC; Ramanathan S; Zainal H; Harun SN
    J Psychoactive Drugs; 2018; 50(3):266-274. PubMed ID: 29558272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia.
    Singh D; Narayanan S; Müller CP; Swogger MT; Chear NJY; Dzulkapli EB; Yusoff NSM; Ramachandram DS; León F; McCurdy CR; Vicknasingam B
    J Ethnopharmacol; 2019 Apr; 233():34-40. PubMed ID: 30594604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the self-reported motivations of kratom (
    Grundmann O; Veltri CA; Morcos D; Knightes D; Smith KE; Singh D; Corazza O; Cinosi E; Martinotti G; Walsh Z; Swogger MT
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):433-444. PubMed ID: 35389321
    [No Abstract]   [Full Text] [Related]  

  • 13. Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia.
    Singh D; Müller CP; Vicknasingam BK; Mansor SM
    J Psychoactive Drugs; 2015; 47(2):125-31. PubMed ID: 25950592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is kratom (
    Leong Abdullah MFI; Tan KL; Narayanan S; Yuvashnee N; Chear NJY; Singh D; Grundmann O; Henningfield JE
    Clin Toxicol (Phila); 2021 May; 59(5):400-408. PubMed ID: 32870119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia.
    Singh D; Narayanan S; Vicknasingam B; Corazza O; Santacroce R; Roman-Urrestarazu A
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28544011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    Singh D; Müller CP; Vicknasingam BK
    Drug Alcohol Depend; 2014 Jun; 139():132-7. PubMed ID: 24698080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of regular kratom (
    Leong Bin Abdullah MFI; Yuvashnee N; Singh D
    Subst Abus; 2021; 42(4):444-449. PubMed ID: 33617750
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of urinary protein profile in regular kratom (
    Jasim RK; Hassan Z; Singh D; Boyer E; Gam LH
    J Addict Dis; 2022; 40(2):235-246. PubMed ID: 34747343
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of kratom (
    Singh D; Narayanan S; Abdullah MFIL; Vicknasingam B
    J Ethn Subst Abuse; 2020 Nov; ():1-11. PubMed ID: 33190622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.